ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
66 906,92
-0,26%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Phathom Pharmaceuticals Inc (PHAT)

  7. Phathom Pharmaceuticals Inc (PHAT) Actualités

PHAT

Phathom Pharmaceuticals (PHAT)

Phathom Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PHAT
DateHeureSourceTitreSymboleSociété
15/05/202414h00GlobeNewswire Inc.Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual MeetingNASDAQ:PHATPhathom Pharmaceuticals Inc
09/05/202422h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PHATPhathom Pharmaceuticals Inc
09/05/202414h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PHATPhathom Pharmaceuticals Inc
09/05/202414h00GlobeNewswire Inc.Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:PHATPhathom Pharmaceuticals Inc
29/04/202414h00GlobeNewswire Inc.Phathom Pharmaceuticals to Report First Quarter 2024 Financial Results and Provide Business Update on Thursday, May 9, 2024NASDAQ:PHATPhathom Pharmaceuticals Inc
03/04/202414h00GlobeNewswire Inc.Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:PHATPhathom Pharmaceuticals Inc
26/03/202413h00GlobeNewswire Inc.Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”NASDAQ:PHATPhathom Pharmaceuticals Inc
07/03/202422h01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PHATPhathom Pharmaceuticals Inc
07/03/202414h00GlobeNewswire Inc.Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:PHATPhathom Pharmaceuticals Inc
29/02/202414h00GlobeNewswire Inc.Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024NASDAQ:PHATPhathom Pharmaceuticals Inc
13/02/202414h00GlobeNewswire Inc.Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial PatientsNASDAQ:PHATPhathom Pharmaceuticals Inc
31/01/202414h00GlobeNewswire Inc.Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:PHATPhathom Pharmaceuticals Inc
23/01/202402h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PHATPhathom Pharmaceuticals Inc
14/12/202314h00GlobeNewswire Inc.Phathom Pharmaceuticals Announces Expansion of Existing Loan and Security Agreement with Hercules CapitalNASDAQ:PHATPhathom Pharmaceuticals Inc
06/12/202314h00GlobeNewswire Inc.Phathom Pharmaceuticals Announces FDA Acceptance for Filing of VOQUEZNA® (vonoprazan) Tablets New Drug Application for the Treatment of Heartburn Associated with Non-Erosive GERDNASDAQ:PHATPhathom Pharmaceuticals Inc
28/11/202314h00GlobeNewswire Inc.Phathom Pharmaceuticals Announces Commercial Availability of VOQUEZNA® (vonoprazan) Tablets, a Powerful First-In-Class PCAB for the Treatment of Erosive GERD and Relief of Associated HeartburnNASDAQ:PHATPhathom Pharmaceuticals Inc
20/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PHATPhathom Pharmaceuticals Inc
09/11/202322h02Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PHATPhathom Pharmaceuticals Inc
09/11/202314h00GlobeNewswire Inc.Phathom Pharmaceuticals Reports Third Quarter 2023 Results and Recent Business UpdatesNASDAQ:PHATPhathom Pharmaceuticals Inc
01/11/202322h50Dow Jones NewsPhathom Pharmaceuticals Gets FDA Approval for Voquezna TreatmentNASDAQ:PHATPhathom Pharmaceuticals Inc
01/11/202322h00GlobeNewswire Inc.Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Treatment of Erosive GERD and Relief of Heartburn Associated with Erosive GERD in AdultsNASDAQ:PHATPhathom Pharmaceuticals Inc
30/10/202313h00GlobeNewswire Inc.Phathom Pharmaceuticals Announces FDA Approval of Reformulated Vonoprazan Tablets for VOQUEZNA® TRIPLE PAK® (vonoprazan, amoxicillin, clarithromycin) and VOQUEZNA® DUAL PAK® (vonoprazan, amoxicillin) for the Treatment of H. pylori Infection in AdultsNASDAQ:PHATPhathom Pharmaceuticals Inc
25/10/202314h01GlobeNewswire Inc.Phathom Pharmaceuticals to Participate in Upcoming Investor ConferencesNASDAQ:PHATPhathom Pharmaceuticals Inc
26/09/202314h01GlobeNewswire Inc.Phathom Pharmaceuticals Announces Vonoprazan NDA Submission for Non-Erosive GERDNASDAQ:PHATPhathom Pharmaceuticals Inc
21/08/202314h00GlobeNewswire Inc.Phathom Pharmaceuticals Announces Submission of Six-Month Stability Data in Support of Erosive GERD New Drug ApplicationNASDAQ:PHATPhathom Pharmaceuticals Inc
10/08/202314h01GlobeNewswire Inc.Phathom Pharmaceuticals Reports Second Quarter 2023 ResultsNASDAQ:PHATPhathom Pharmaceuticals Inc
17/07/202322h02Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:PHATPhathom Pharmaceuticals Inc
15/06/202315h12Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:PHATPhathom Pharmaceuticals Inc
15/06/202315h05Edgar (US Regulatory)Tender Offer Statement by Issuer (sc To-i)NASDAQ:PHATPhathom Pharmaceuticals Inc
12/06/202315h04Dow Jones NewsFDA Accepts Phathom Pharmaceuticals' Resubmission for VonoprazanNASDAQ:PHATPhathom Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PHAT

Dernières Valeurs Consultées

NASDAQ
GTIMD
ASX
CMA
Centuria Metropolitan REIT
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés